TITLE

PSYCHOLOGICAL STRESS IN IBD: NEW INSIGHTS INTO PATHOGENIC AND THERAPEUTIC IMPLICATIONS

AUTHOR(S)
Mawdsley, J. E.; Rampton, D. S.
PUB. DATE
October 2005
SOURCE
Gut;Oct2005, Vol. 54 Issue 10, p1481
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Psychological stress has long been reported anecdotally to increase disease activity in inflammatory bowel disease (IBD), and recent well designed studies have confirmed that adverse life events, chronic stress, and depression increase the likelihood of relapse in patients with quiescent IBD. This evidence is increasingly supported by studies of experimental stress in animal models of colitis. With the evolving concept of psychoneuroimmunology, the mechanisms by which the nervous system can affect immune function at both systemic and gut mucosal levels are gradually becoming apparent. Recent data suggest that stress induced alterations in gastrointestinal inflammation may be mediated through changes in hypothalamic-pituitary- adrenal (HPA) axis function and alterations in bacterial-mucosal interactions, and via mucosal mast cells and mediators such as corticotrophin releasing factor (CRF). To date, the therapeutic opportunities offered by stress reduction therapy remain largely unexplored, in part because of methodological difficulties of such studies. This paper reviews recent advances in our understanding of the pathogenic role of psychological stress in IBD and emphasises the need for controlled studies of the therapeutic potential of stress reduction.
ACCESSION #
18457698

 

Related Articles

  • Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation. Straub, R. H.; Grum, F.; Strauch, U.; Capellino, S.; Bataille, F.; Bleich, A.; Faik, W.; Scholmerich, J.; Obermeier, F. // Gut;Jul2008, Vol. 57 Issue 7, p911 

    Background: Substance P (SP) is a pro-inflammatory neuropeptide in colitis, whereas sympathetic neurotransmitters are anti-inflammatory at high concentrations. Aim and methods: In all layers of the colon, nerve fibre densities of SP+ and sympathetic nerve fibres were investigated (22 Crohn's...

  • Activation Pattern of Signal Transducers and Activators of Transcription (STAT) Factors in Inflammatory Bowel Diseases. Mudter, Jonas; Weigmann, Benno; Bartsch, Brigitte; Kiesslich, Ralf; Strand, Dennis; Galle, Peter R.; Lehr, Hans A.; Schmidt, Jan; Neurath, Markus F. // American Journal of Gastroenterology;Jan2005, Vol. 100 Issue 1, p64 

    OJECTIVES: Cytokine signaling pathways involving transcription factors of the signal transducers and activators of transcription (STAT) family play a key role in the pathogenesis of inflammatory bowel diseases (IBD). STAT proteins are latent cytoplasmic transcription factors that induce...

  • Pitfalls in the Interpretation of Nonneoplastic Mucosal Biopsies in Inflammatory Bowel Disease. Yantiss, Rhonda K.; Odze, Robert D. // American Journal of Gastroenterology;Apr2007, Vol. 102 Issue 4, p890 

    This review provides a summary of common diagnostic problems encountered by both pathologists and gastroenterologists when evaluating patients with diarrhea and in whom inflammatory bowel disease (IBD) is suspected. The two most common forms of IBD, ulcerative colitis (UC) and Crohn's disease...

  • UIcerative colitis and crohn's disease. Price, Jim // GP: General Practitioner;5/26/2006, p26 

    The article offers an update on inflammatory bowel disorders. Inflammatory bowel disease is an umbrella term covering a range of conditions, the two most common being ulcerative colitis (CD) and Crohn's disease (CD). UC is characterized by inflammation of the mucosal layer of the colon. CD is...

  • CARD15 and HLA DRB1 Alleles Influence Susceptibility and Disease Localization in Crohn's Disease. Newman, Bill; Silverberg, Mark S.; Xiangjun Gu; Qing Zhang; Lazaro, Ana; Steinhart, A. Hillary; Greenberg, Gordon R.; Griffiths, Anne M.; McLeod, Robin S.; Cohen, Zane; Fernández-Viña, Marcelo; Amos, Christopher I.; Siminovitch, Katherine // American Journal of Gastroenterology;Feb2004, Vol. 99 Issue 2, p306 

    OBJECTIVES: Crohn's disease (CD) is a chronic inflammatory disease of the gut associated with allelic variants of CARD15 and HLA-DRB1 genes. We investigated the prevalence and effects of these variants in a Canadian CD cohort.METHODS: 507 unrelated CD patients were genotyped for the three major...

  • VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy. Cromer, Walter E.; Ganta, Chaitanya V.; Patel, Mihir; Traylor, James; Kevil, Christopher G.; Alexander, J. Steven; Mathis, J. Michael // Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1 

    Background: Ulcerative colitis (UC) is the most common form of inflammatory bowel disease in the USA. A key component of UC is the increase in inflammatory angiogenesis of the colon during active disease. This increase is driven to a great extent by the over expression of VEGF-A. Recently,...

  • Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer. Lowe, Emily L.; Crother, Timothy R.; Rabizadeh, Shervin; Bing Hu; Hanlin Wang; Shuang Chen; Shimada, Kenichi; Wong, Michelle H.; Michelsen, Kathrin S.; Arditi, Moshe // PLoS ONE;2010, Vol. 5 Issue 9, p1 

    Inflammatory bowel disease (IBD) is a disorder of chronic inflammation with increased susceptibility to colorectal cancer. The etiology of IBD is unclear but thought to result from a dysregulated adaptive and innate immune response to microbial products in a genetically susceptible host....

  • Clinical Expression of Inflammatory Bowel Diseases - A Retrospective Population-Based Cohort Study; Vukovarsko-Srijemska County, Croatia, 2010. Pezerović, Davorin; Žulj, Marinko; Klarin, Ivo; Majnarić, Ljiljana; Včev, Ivan; Včev, Aleksandar // Collegium Antropologicum;Sep2013, Vol. 37 Issue 3, p919 

    Clinical characteristics of the cohort of 150 patients with inflammatory bowel diseases, ulcerative colitis (UC) and Crohn's disease (CD), Vukovarsko-Srijemska County, Croatia, were retrospectively assessed. UC was clinically presented with frequent passage of bloody, slimy stools, while...

  • Hydroxylases as therapeutic targets in inflammatory bowel disease. Cummins, Eoin P.; Doherty, Glen A.; Taylor, Cormac T. // Laboratory Investigation (00236837);Apr2013, Vol. 93 Issue 4, p378 

    Inflammatory bowel disease (IBD) is a common and debilitating clinical disorder comprising ulcerative colitis and Crohn disease. IBD occurs when inappropriate immunological activity in the intestinal mucosa results in epithelial barrier dysfunction leading to exposure of the mucosal immune...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics